deregulation

Presidential administrations have taken dramatically different approaches to regulation over the last ten years.

The Trump Administration’s deregulatory response to COVID-19 is temporary and will not have a lasting impact on U.S. health care.

The Administration has taken an aggressive approach in using legal tools to advance its regulatory agenda.

The Trump Administration’s 1-in-2-out policy is more of an ineffective symbol than an action toward deregulation.

The Administration quietly released data showing its deregulatory success has been limited.

Setting a regulatory budget at a cost of zero ignores evidence of regulation’s high return on investment.

Scholars report that White House review exerts a deregulatory influence on agency rulemaking.

The latest Economic Report of the President highlights the importance of studying cumulative regulatory costs.

Scholar argues that spreading regulatory authority may insulate programs from future deregulatory pressures.

Much support for government deregulation originates from left-wing thought.

President Trump’s deregulation efforts have resulted in fewer career experts at regulatory agencies.

Presidents Reagan and Trump differ on approaches to social and economic regulation.